http://www.congoo.com/feed/newschannelsfeed.aspx?chid=73&catid=47News Feed for - Merck-and-Cohttp://www.congoo.com/news/addstorycomment.aspx?st=96349765&Channel_ID=73&Category_ID=472009-11-23T23:35:00CHARLOTTE, NC (BRAIN)-Starting in the 2010 season, Team Quick Step cyclists will be riding bicycles produced by Eddy Merckx Cycles. The agreement is for three years. 'We want to grow from being a family Bicycle Retailer and Industry Newshttp://www.congoo.com/news/addstorycomment.aspx?st=96348943&Channel_ID=73&Category_ID=472009-11-24T00:11:00Merck has been granted a motion for summary judgment dismissing all claims by the Texas state attorney generalâ??s office, which sought a refund of Medicaid funds spent on the withdrawn painkiller Vioxx.FDA Newshttp://www.congoo.com/news/addstorycomment.aspx?st=96347464&Channel_ID=73&Category_ID=472009-11-23T23:46:00Provides lessons for post-market pharmaceutical safety Evidence of cardiovascular risks associated with taking Vioxx, the popular, nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified Red Orbithttp://www.congoo.com/news/addstorycomment.aspx?st=96344709&Channel_ID=73&Category_ID=472009-11-23T23:25:00By Julie Steenhuysen CHICAGO (Reuters) - Heart risks from taking Merck & Co Inc's painkiller Vioxx could have been detected more than three years before the company withdrew the drug from the market in Reutershttp://www.congoo.com/news/addstorycomment.aspx?st=96336430&Channel_ID=73&Category_ID=472009-11-23T20:05:00$4 Million Alliance Program Supports Future Leaders in STEM Fields Scholarship and Internship Guide Available at www. AllianceScholars.org WASHINGTON, Nov. 23 /PRNewswire-USNewswire/ -- 'Mr. President, Houston Chroniclehttp://www.congoo.com/news/addstorycomment.aspx?st=96335051&Channel_ID=73&Category_ID=472009-11-23T19:47:00WASHINGTON, Nov. 23, 2009 â?? The American Chemical Society (ACS) today commended President Obama for announcing the establishment of National Lab Day, a major new science education initiative designed EurekAlert!http://www.congoo.com/news/addstorycomment.aspx?st=96332818&Channel_ID=73&Category_ID=472009-11-23T19:28:00NEW YORK -(Dow Jones)- A federal judge has dismissed the second of three so- called 'bellwether' cases over Merck & Co.'s (MRK) osteoporosis drug Fosamax. In an order Monday, U.S. District Judge John CNN Moneyhttp://www.congoo.com/news/addstorycomment.aspx?st=96331041&Channel_ID=73&Category_ID=472009-11-23T20:10:00So what is the bottom line on the continuing kerfluffle over the cholesterol drugs Zetia and Vytorin, sold by Merck? The basic problem is this: What should patients and doctors do when insufficient data Forbes.comhttp://www.congoo.com/news/addstorycomment.aspx?st=96330421&Channel_ID=73&Category_ID=472009-11-23T19:05:00NEW YORK, Nov 23 (Reuters) - A federal judge has dismissed a lawsuit alleging that Merck & Co's (MRK.N) osteoporosis drug Fosamax causes jaw damage, more than two months after a jury deadlocked in a case Reutershttp://www.congoo.com/news/addstorycomment.aspx?st=96328294&Channel_ID=73&Category_ID=472009-11-23T19:21:00CAMBRIDGE, Mass., Nov. 23 /PRNewswire/ -- Ligon Discovery, Inc., which uses proprietary small molecule microarray technology to find drugs against high-value targets, today announced the appointment of Red Orbithttp://www.congoo.com/news/addstorycomment.aspx?st=96321058&Channel_ID=73&Category_ID=472009-11-23T16:00:00/quotes/comstock/10t!drg.x Nyse Arca Pharmaceutical (DRG) /marketstate/country/US The market is open10:29:16 am The market is closed10:29:16 am Volume 0.00 Real time quotes Add to portfolio $DRG Create Cafepharmahttp://www.congoo.com/news/addstorycomment.aspx?st=96320808&Channel_ID=73&Category_ID=472009-11-23T15:58:00The marriage between Merck (NYSE: MRK) and Schering-Plough is already starting to produce offspring. The only question is whether the fertility treatment for its pipeline was worth it. Today, the drugmaker Cafepharmahttp://www.congoo.com/news/addstorycomment.aspx?st=96318359&Channel_ID=73&Category_ID=472009-11-23T15:38:00Merck recently outlined its global strategy following the completion of Merck's merger with Schering-Plough Corporation. The new Merck, operating as MSD outside the US and Canada is a global healthcare Express Pharmahttp://www.congoo.com/news/addstorycomment.aspx?st=96315923&Channel_ID=73&Category_ID=472009-11-23T18:57:00The latest set of opinions from the European Medicines Agencyâ??s Committee for Medicinal Products for Human Use includes a recommendation for Merck & Coâ??s fertility treatment Elonva and a rejection Pharma Timeshttp://www.congoo.com/news/addstorycomment.aspx?st=96310594&Channel_ID=73&Category_ID=472009-11-23T13:40:00Merck (NYSE: MRK) said today that Travis County, Texas District Court Judge Scott H. Jenkins granted Merck's motion for summary judgment, dismissing all claims in a VIOXX-related lawsuit filed on behalf Street Insiderhttp://www.congoo.com/news/addstorycomment.aspx?st=96307498&Channel_ID=73&Category_ID=472009-11-24T00:05:00Merck Wins Summary Judgment in Second Federal Bellwether Case Involving FOSAMAXBusiness Wire UKhttp://www.congoo.com/news/addstorycomment.aspx?st=96304188&Channel_ID=73&Category_ID=472009-11-24T00:10:00NEW YORK - A Texas court has dismissed a lawsuit brought by the state against drugmaker Merck & Co that sought a refund for money spent on the withdrawn Vioxx pain treatment, the company said on Monday.Judge CNBChttp://www.congoo.com/news/addstorycomment.aspx?st=96302113&Channel_ID=73&Category_ID=472009-11-24T00:10:00JeeYeon ParkCNBC News AssociateWith the health care debate continuing, how can investors make money in the sector? Barbara Ryan, managing director and senior pharmaceuticals analyst at Deutsche Bank Securities, CNBChttp://www.congoo.com/news/addstorycomment.aspx?st=96263071&Channel_ID=73&Category_ID=472009-11-23T01:10:00Nov 2009 LONDON (SHARECAST) - US shares continued their decline led by a sharp fall for Nasdaq following disappointing figures from PC supplier Dell last night. Dell's third-quarter revenue and profits ShareCasthttp://www.congoo.com/news/addstorycomment.aspx?st=96224510&Channel_ID=73&Category_ID=472009-11-22T09:36:00To the Editor: I am writing to provide balance to your one-sided account entitled '' (The Chronicle, October 25). First, in three separate head-to-head clinical studies, Vytorin was demonstrated to lower Chronicle of Higher Educationhttp://www.congoo.com/news/addstorycomment.aspx?st=96219548&Channel_ID=73&Category_ID=472009-11-22T07:58:00Drug developer Mercks shares gained after a European advisory committee recommended approval for its fertility drug Elonva. The European Medicines Agency panel made the recommendation. If approved by Boston Globehttp://www.congoo.com/news/addstorycomment.aspx?st=96198979&Channel_ID=73&Category_ID=472009-11-23T01:04:00US Stocks Close Lower as Dell Weighs on Tech A bigger-than-expected drop in Dell's latest quarterly earnings and a pullback for global industrials, including Caterpillar, pushed stocks lower on Friday, Huntleys Newsletterhttp://www.congoo.com/news/addstorycomment.aspx?st=96191461&Channel_ID=73&Category_ID=472009-11-21T23:56:00BETHESDA, Md.--Federal health experts said Wednesday an updated version of Pfizer's best-selling anti-infection vaccine is safe and effective for infants and toddlers, despite company studies that failed Drugs.comhttp://www.congoo.com/news/addstorycomment.aspx?st=96177047&Channel_ID=73&Category_ID=472009-11-22T08:59:00Progress Represents a Major Step toward the Goal of Interrupting Transmission of River Blindness in the Americas by 2012 WASHINGTON, Nov. 21 /PRNewswire-USNewswire/ -- A regional initiative launched in Business First of Louisvillehttp://www.congoo.com/news/addstorycomment.aspx?st=96140284&Channel_ID=73&Category_ID=472009-11-23T15:59:00Zetia, showed no measurable change in arterial plaque build-up. That result could give doctors pause for thought and has already created a stir among Merck investors concerned about the studys impact Cafepharma